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Abstract 
 
Fulminant haemorrhage in cervical cancer leads to severe anaemia and haemodynamic instability. Palliative 
management includes vaginal packing as temporary measure, radiotherapy and other invasive surgical procedures. 
High dose emergency chemotherapy is not commonly implemented particularly when complicated with anaemia and 
renal impairment. We discuss three case series on the usefulness of high dose chemotherapy to combat bleeding from 
cervical cancer as an emergency treatment. The first case was clinically staged as operable 2A disease with severe 
anaemia due to bleeding from the tumour mass. The haemoglobin was corrected by blood transfusion while the 
bleeding was being arrested by high dose chemotherapy. The second case was inoperable with invasion to the 
bladder mucosa. She had frank haematuria and bleeding from the tumour with severe anaemia. A course of 
chemotherapy and blood transfusion controlled the bleeding and anaemia was corrected. The third case presented 
late with obstructive uropathy and anaemia. She required dialysis, blood transfusion and high dose emergency 
chemotherapy to stop the bleeding before undergoing urinary diversion after an unsuccessful ureteric stenting. High 
dose chemotherapy consisting cisplatin, vincristine, bleomycin and mitomycin-C has a clinical value in arresting 
fulminant haemorrhage in cervical cancer. 
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Introduction 
 
Even though the incidence of cervical cancer shows a 
downward trend in many developed countries resulting 
from effective preinvasive cervical screening and 
vaccination, yet advanced disease is still not 
uncommon in developing countries (1).   
 
Urinary system is commonly affected due to close 
proximity to cervix and ureters running in the 
parametrium, approximately two centimeters from the 
cervix before entering the bladder. Lateral tumour 
extension-encasing the distal ureter leading to 
hydroureter, hydroneprosis and finally renal 
impairment. The prognosis is guarded with median 
survival of three to seven months (2). 
 
Bleeding from the tumour can be torrential and difficult 
to arrest causing haemodynamic instability to the 
extend of death. Vaginal packing with Monsel solution 
works temporarily especially in non massive 
haemorrhage. Radiotherapy and brachytherapy are 
commonly used not only for definitive treatment in 
early stage but also palliative measures to stop 
bleeding. Other options could be embolization of the 
uterine arteries, ligation of feeding vessels, surgical 
resection and stereotactic radiosurgery, with varying 
successful rate and availability (3). 
 
Case Report 
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Generally chemotherapy is administered singly in 
advanced cervical cancer or as neoadjuvant in 
inoperable or bulky tumour. Chemotherapy is not 
particularly used as a rescue measure to stop bleeding 
as it is theoretically time consuming and relatively 
contraindicated in anaemic patients. More so, in 
uropathic patients where poor clearance is anticipated, 
it is not an advisable option. To date there is no report 
published on the evaluation of clinical benefits of high 
dose chemotherapy in emergency situation to arrest 
bleeding from the tumour. 
 
Case Report 
 
Case 1: 
A 48-year-old, grandmultipara presented with 
prolonged per vagina bleeding for three weeks. It was 
associated with anaemia and constitutional symptoms. 
She was previously healthy, with six previous normal 
vaginal deliveries. She never had any Pap smear done. 
Assessment revealed a fungating cervical mass 7x8cm 
with contact bleeding. It has involved the upper half of 
the vaginal wall and both parametriums were thickened. 
The renal function was acceptable but she was severely 
anaemic with haemoglobin of 4 g/dL. She was 
transfused with four units of blood, but the bleeding 
persisted. As radiotherapy was not readily available to 
arrest the bleeding, a course of chemotherapy (cisplatin, 
vinscristin, bleomycin and mitomycin C) was 
administered with an excellent result. The bleeding 
finally stopped and two weeks later, haemoglobin 
improved to 10 g/dL. The tumour shrunk to 3x5 cm and 
the second course of chemotherapy was administered 
before the tumour became operable. 
 
Case 2: 
A 39-year-old, multipara presented with abnormal 
vaginal bleeding for one month, associated with lower 
abdominal discomfort. She also had intermittent 
haematuria. She was pale with haemoglobin of 5 g/dL. 
There was oozing of blood from the vagina with an 
exophytic growth occupying the upper half of the 
vagina. The friable tissue obtained confirmed squamous 
cell carcinoma with extension to bladder mucosa. The 
bleeding continued and she was persistently anaemic 
despite of four units of blood transfusion. Emergency 
palliative chemotherapy (cisplatin, vinscristin, 
bleomycin and mitomycin C) was administered with 
spontaneous remission of the bleeding. 
 
Case 3: 
A 45-year-old, nulliparous, presented with anuria and 
ureamic symptoms. She had history of persistent per 
vaginal bleeding since three months prior to the 
presentation but did not seek any medical advice. She 
was dehydrated and pale. A contact bleeding of 5x5 
cm exophytic growth occupying the upper two third of 
vagina was confirmed to be adenosquamous cervical 
carcinoma. The haemoglobin was 4 g/dL and blood 
gases revealed metabolic acidosis. Serum urea and 
creatinine was 15 mmol/L and 150 mmol/L 
respectively. Ultrasound kidney, ureter and bladder 
revealed bilateral hydronephrosis. Vaginal packing 
failed to arrest the bleeding from the tumour. 
Concurrent haemodialysis and chemotherapy were 
administered to arrest the bleeding while packed cells 
were being infused. The patient and relatives were 
made aware of the high risk and possible benefits from 
the chemotherapy at this emergency situation. The 
bleeding had stopped following the chemotherapy and 
she was subjected to bilateral ureteric stenting, which 
however was not successful, requiring bilateral 
uretero-neocystotomy to divert the blockage. 
 
Discussion 
 
Bleeding cervical cancer is not uncommon and could 
happen at various stages. Nevertheless, it occurs 
frequently in the advanced stage of a bulky tumour. At 
the operable stage, management issue is less 
contentious as either chemoradiation or radical surgery 
following correction of anaemia is the optimum 
approach. Bleeding at advanced stage requires 
palliative measures to stop the bleeding for 
improvement of patient’s general wellbeing.  Palliative 
pelvic radiotherapy induces tumour necrosis, regresses 
its growth and arrests the bleeding (4). This 
particularly is applicable in the centre where 
radiotherapy facility is widely available, however this 
is debatable in those poor resources units. Is there any 
role of emergency chemotherapy to stop the tumour 
bleeding? There is very limited data discussed on this 
issue, in fact no proper randomized controlled trial to 
assess its efficacy, safety and outcomes. 
 
The three case series illustrated the benefit of 
‘emergency chemotherapy’ in term of palliative 
measures in order to arrest bleeding from a tumour, 
besides its renowned effect as neoadjuvant modality 
before radical surgery is made possible. 
 
In clinically fit patients, chemotherapeutic agents are 
generously administrated without much concern of its’ 
side effects and clearance, but those with renal 
impairment from tumour compression have created 
uncertainties. Further deterioration is anticipated if 
slim chance of recuperation does not occurr. The third 
case prove proactive management which included 
correction of anaemia, haemodialysis with concurrent 
chemotherapy given had stopped the bleeding, shrunk 
the tumour mass and further intervention was made 
possible. Obstructive uropathy which most commonly 
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implicated with cervical malignancy is reversible if 
timely intervention with the introduction of 
chemotherapy. In severe renal parenchymal disease, 
chemotherapy is deemed dangerous and life 
threatening with contraindication especially of those 
with cortical thickness of less than 13mm (5). Hence, 
proper individualized assessment is indeed mandatory 
before instituting treatment on top of comprehensive 
counseling.     
 
Many case reports demonstrate ureteric stenting before 
chemo radiation in patients with hydronephrosis, 
howed no deterioration in renal function yet it is an 
effective procedure (6,7). It is of more concern when 
the tumour bleeds in obstructive uropathic patients? 
Obviously arresting the bleeding is the priority where 
failure of doing so will jeopardize the lives of these 
women. Hence the use of high dose chemotherapy 
(bleomycin, vincrsitine, mitomycin and cisplatin) is 
found to be effective to combat the bleeding, while 
dialyzing the patient to prevent further deterioration of 
renal function. Ureteric stenting or even diversion 
could be later performed once it is feasible. 
 
Conclusion 
 
High dose ‘emergency chemotherapy’ has a proven role 
in arresting bleeding cervical cancer of various stages 
even in an advanced disease with obstructive uropathy, 
with concurrent dialysis before urinary diversion. 
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